TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE D-

NCT07521475: EVOLVE: Evaluation of the Fully Closed Loop Omnipod® System for Safety and Efficacy in Adults With Type 2 Diabetes

Sponsor: Insulet Corporation · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 350 pts

Competing Trials Overlap

11 Active Trials

Excess Burn Exposure

$6,640,000

Rescue Site Savings

+$4,382,400

Unlock Full NCT07521475 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07521475 Rescue Dossier →